The Vancouver Sun reports in its Monday edition that the first week of 2018 has seen several deals in Canada's cannabis industry -- a busy start to what is expected to be a busy year. Postmedia's Geoff Zochodne writes that Victoria's Emerald Health Therapeutics, a licensed medical marijuana producer, said Wednesday that an unnamed, "Canadian institutional accredited investor" had agreed to buy a $25-million chunk of the cannabis company through a prospectus and secondary sale. Also Wednesday, Ontario's Aphria said that it had closed a $115-million bought-deal share offering, with some of the proceeds earmarked for "strategic investments to enhance the Company's product offerings or cultivation capabilities." Mr. Zochodne adds that Golden Leaf Holdings, a Canadian cannabis oil company with business operations in Portland, Ore., said Tuesday that it had closed its previously announced purchase of Medical Marijuana Group Consulting, a company that "secures" medical marijuana patients and refers them to licensed producers. Golden Leaf paid $5-million in stock for MMGC, the Post adds.